Winter 2016 Residents’ CE Seminar
February 20, 2016
8:00am – 11:45am CST
Sister Coleman Room – Lower Level, Avera Prairie Center
Avera McKennan Hospital & University Health Center
Sioux Falls, SD
Joint Providership:
South Dakota Society of Health-System Pharmacists
South Dakota State University College of Pharmacy
___________________________________________________
The South Dakota State University College of Pharmacy is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education. The Universal Program
Identification numbers for this program are listed immediately below:
___________________________________
Agenda: Saturday, February 20, 2016
8:00-8:15am Welcome / Registration
8:15-8:45am
“Superman’s Kryptonite: Long Acting Anticoagulant Rodenticide Poisoning”
Alicia Christensen, Pharm.D.
(Knowledge-based CPE)
.
#0063-9999-16-001-L05-P 0.05 CEUs
#0063-9999-16-001-L05-T 0.05 CEUs
8:45-9:15am
“Giving HIV Treatment a Boost: Updates to the HIV Treatment Guidelines”
Emily Zoelle, Pharm.D.
(Knowledge-based CPE)
#0063-9999-16-002-L02-P 0.05 CEUs
#0063-9999-16-002-L02-T 0.05 CEUs
”Effects of Empagliflozin on Cardiovascular Outcomes & Mortality in Type II Diabetes”
Sarah Ahrndt, Pharm.D.
(Knowledge-based CPE)
#0063-9999-16-003-L01-P 0.05 CEUs
#0063-9999-16-003-L01-T 0.05 CEUs
9:45-10:00am Break
9:15-9:45am
10:00-10:30am “Crohn’s Disease Management”
Molly Mortenson, Pharm.D.
(Knowledge-based CPE)
#0063-9999-16-004-L01-P 0.05 CEUs
#0063-9999-16-004-L01-T 0.05 CEUs
10:30-11:00am “When the Seizing Won’t Cease: Reach for the Ketamine” (Knowledge-based CPE)
Shelby Nielsen, Pharm.D.
#0063-9999-16-005-L01-P 0.05 CEUs
#0063-9999-16-005-L01-T 0.05 CEUs
11:00-11:30pm “Antenatal Antidepressant Use and Autism Spectrum Disorder”
Gerard Kokett, Pharm.D.
(Knowledge-based CPE)
#0063-9999-16-006-L01-P 0.05 CEUs
#0063-9999-16-006-L01-T 0.05 CEUs
11:30-11:45pm Wrap-up / evaluations / CE Credit reconciliation
_____________________________________________________
It is the policy of the South Dakota State University College of Pharmacy that all
continuing education programming present evidence-based information that is non-commercial
and professionally objective, not promoting, nor appearing to promote, any specific product or service.
Target Audience: This program is suitable for pharmacists and pharmacy technicians – hospital, community
pharmacy and consulting.
C.E. Credit: Successful completion of each CE session requires continuous attendance, completion of
the C.E. Verification, and completion of the evaluation / /learning assessment form. Credit may be
earned for individual sessions. A total of 0.3 CEUs (3.0 contact hours) of continuing pharmacy
education credit may be earned at this seminar.
Pharmacists and Technicians must provide their CPE ID number and their personal MM/DD on the CPE
Verification Form which will be filled out at the Seminar – in order to receive CE credit. Information
provided late may jeopardize the credit earned. Credit will be uploaded to participants’ eProfile accounts
within 21 business days.
C.E. Registration: Pharmacist participants - please go to www.sdshp.com to register. Registration is
important, since this will provide the mechanism for handouts to be sent out in advance of the meeting.. If
people have problems accessing the registration site from work, they should be able to access from their
home computer. SDSHP will also be sending out emails.
C.E. Fee: There is no fee for this program for SDSHP members. Non-members fee is $75.
C.E. Handouts: Handouts will be emailed out to pre-registrants to access electronically or print out.
____________________________________________________
Faculty Presenters:
Alicia Christensen, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University
Health Center, Sioux Falls, SD
“Superman’s Kryptonite: Long Acting Anticoagulant Rodenticide Poisoning”
Pharmacist Learning Objectives: 1. Explain the mechanism of action of long acting anticoagulant
rodenticides; 2. List medication treatment options upon initial exposure to long acting anticoagulant
rodenticide poisoning; 3. State dosing strategies for long term management of long acting anticoagulant
rodenticide poisoning treatment.
Pharmacy Technician Learning Objectives: 1. State the mortality rate among long acting anticoagulant
rodenticide exposures; 2. Identify the most frequently used medication to treat long acting anticoagulant
rodenticide poisonings; 3. Explain the average duration of treatment of long acting anticoagulant rodenticide
poisoning.
Emily Zoelle, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University Health
Center, Sioux Falls, SD
“Giving HIV Treatment a Boost: Updates to the HIV Treatment Guidelines”
Pharmacist Learning Objectives: 1. Identify appropriate treatment regimens for HIV-1 positive anti-retroviral
naïve patients; 2. Describe the role of ritonavir and cobicistat in an anti-retroviral treatment regimen; 3. List
patient-specific factors that should be considered when choosing an anti-retroviral treatment regimen.
Pharmacy Technician Learning Objectives: 1. Identify common anti-retroviral medications; 2. List common comorbidities that may influence the selection of retroviral medications; 3. Describe proper storage and handling
of anti-retroviral medications.
Sarah M. Ahrndt, Pharm.D., PGY1 Pharmacy Practice Resident, VA Health Care System, Sioux Falls, SD
“Effects of Empagliflozin on Cardiovascular Outcomes and Mortality in Type II Diabetes”
Pharmacist Learning Objectives: 1. Describe empagliflozin’s mechanism of action, current place in therapy,
adverse effects, and dosing regimen; 2. Identify empagliflozin’s effect on cardiovascular risk factors such as
blood pressure, weight, arterial stiffness, and vascular resistance; 3. Evaluate the statistical and clinical
significance of empagliflozin’s effect on cardiovascular and mortality outcomes in patients with Type II
diabetes.
Pharmacy Technician Learning Objectives: 1. Describe empagliflozin’s mechanism of action; 2. Identify
empagliflozin’s adverse effects and explain its appropriate dosing regimen; 3. Summarize empagliflozin’s cost
profile and describe its proper storage.
Molly Mortenson, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University
Health Center, Sioux Falls, SD
“Crohn’s Disease Management”
Pharmacist Learning Objectives: 1. Describe the pathophysiology of Crohn’s Disease; 2. Explain the
mechanisms of action of the primary medications used to treat Crohn’s Disease; 3. Identify potential
complications that can develop from drug therapy.
Pharmacy Technician Learning Objectives: 1. Identify key signs and symptoms of Crohn’s Disease; 2. List
medications frequently used to treat Crohn’s Disease; 3. Describe the pathophysiology of Crohn’s Disease.
Shelby L. Nielsen, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University Health
Center, Sioux Falls, SD
“When the Seizing Won’t Cease: Reach for the Ketamine”
Pharmacist Learning Objectives: 1. Summarize the current guideline recommendations for the treatment of
refractory status epilepticus; 2. Describe the mechanism of action, drug class, and place in therapy for each
medication for the treatment of refractory status epilepticus; 3. Evaluate the potential advantages of ketamine
for the treatment of refractory status epilepticus in comparison to other recommendations; 4. Identify the
appropriate place in therapy for the use of ketamine in the treatment of refractory status epilepticus.
Pharmacy Technician Learning Objectives: 1. Describe the signs and symptoms associated with refractory
status epilepticus; 2. List the medications frequently used for treatment of refractory status epilepticus;
3. Identify the common side effects associated with the use of ketamine.
Gerard Kokett, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University Health
Center, Sioux Falls, SD
“Antenatal Antidepressant Use and Autism Spectrum Disorder”
Pharmacist Learning Objectives: 1. Describe the proposed mechanism of serotonin leading to autism in early
childhood; 2. Evaluate recent literature describing antidepressant use associated with autism; 3. Provide
recommendations for prescribers regarding risks of antidepressant use during pregnancy; 4. Describe the
pharmacist’s role in counseling expecting mothers.
Pharmacy Technician Learning Objectives: 1. Describe the proposed association of antidepressants and autism;
2. Describe the signs and symptoms of Autism Spectrum Disorder; 3. Identify possible medications or
immunizations previously associated with autism.
____________________________________________
Guidance and oversight on CPE development was provided by Residency Directors:
Dr. Glenn Voss, Pharm.D. – Avera Mckennan Hospital & University Health Center, Sioux Falls
Dr. Kelley Oehlke, Pharm.D. – VA Hospital, Sioux Falls, SD